NIH-funded research NIH-funded research

Growing and testing gut microbes to restore a healthy microbiome

Official title: Designing a High-Throughput Platform to Bioprospect the Human Microbiome and ManipulateIts Iinterplay with Host Environments

Funded at Carnegie-Mellon University · NIH-11360439 · Data updated 2026-11-12

This project will build a lab system to grow many gut microbes so doctors can develop personalized microbe mixes to help people with gut, immune, heart, or memory problems.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCarnegie-Mellon University
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 8, 2022
Project endAugust 31, 2027
Funding year2025
Award (this year)$817,268
NIH project number4DP2GM149553-03
Project IDNIH-11360439 on NIH RePORTER

Who could benefit from this research

Could help

People with conditions linked to gut dysbiosis—such as recurrent C. difficile infection, inflammatory or metabolic disorders, certain cardiovascular issues, or cognitive changes—would be the most likely future candidates.

Less likely to help

People without gut-related conditions or those seeking an immediate clinical treatment are unlikely to benefit now, because the work is primarily laboratory development rather than a therapy trial.

What this research studies

Researchers are creating tiny lab devices that can capture and grow many different gut bacteria, including species that are hard to culture today. They will use these devices to rebuild microbial communities and test combinations that could restore balance in the gut and support immune, metabolic, cardiovascular, and cognitive health. The team plans to work with microbes from human samples and reconstruct communities in controlled environments to learn which mixes are beneficial. The goal is to enable future personalized microbial therapies based on a patient’s own microbes or selected isolates.

Why it matters

Potential benefit: If successful, this could enable personalized microbial treatments that restore gut balance and help prevent or treat infections, inflammation, metabolic, cardiovascular, and cognitive problems.

How similar studies have gone: Related approaches like fecal microbiota transplant have helped C. difficile, but high-throughput culture of previously unculturable species and personalized reconstruction of communities is largely new.

Where this research is happening

  • Carnegie-Mellon University
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Niepa, Tagbo Herman Roland — Carnegie-Mellon University
  • Study coordinator: Niepa, Tagbo Herman Roland

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.